CBUC:XETRA:XETRA-iShares MSCI USA ESG Enhanced UCITS ETF EUR Hedged Acc (EUR)

ETF | Others |

Last Closing

USD 5.788

Change

0.00 (0.00)%

Market Cap

USD 0.03B

Volume

0.08M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.66 (+1.30%)

USD 548.90B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.21 (+1.26%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.31 (+1.16%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.33 (+1.20%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.34 (+1.42%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+1.70 (+1.16%)

USD 103.20B
JARI:XETRA Amundi Index Solutions - Amund..

+0.45 (+1.01%)

USD 102.92B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.67 (+1.32%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.34 (+0.25%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.28 (+1.28%)

USD 79.79B

ETFs Containing CBUC:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.02% 77% C+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.02% 77% C+ 76% C+
Trailing 12 Months  
Capital Gain 20.96% 77% C+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.96% 77% C+ 77% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.33% 59% D- 58% F
Dividend Return 6.33% 58% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.85% 56% F 65% D
Risk Adjusted Return 58.30% 64% D 67% D+
Market Capitalization 0.03B 18% F 16% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.